Translating inflammatory bowel disease research into clinical medicine.
Recent studies have provided important insights into the pathogenesis of inflammatory bowel disease (IBD). The development of new therapeutic agents has been triggered by basic research and studies in mouse models of IBD. It is expected that improved translational research will lead to optimized therapy and new individualized treatment options.
Neurath
Markus F
MF
Department of Medicine, University of Erlangen-Nürnberg, 91054 Erlangen, Germany. markus.neurath@uk-erlangen.de
Finotto
Susetta
S
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D004195:Disease Models, Animal; D055808:Drug Discovery; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D007378:Interleukins / Q000276:immunology; D012157:Mononuclear Phagocyte System / Q000276:immunology
D000893:Anti-Inflammatory Agents; D007378:Interleukins